Media Relations

If you are a journalist with a question about Lundbeck or would like to request an interview, please contact Media Relations – and we will get back to you. Please note this service is for journalists and other media professionals only. Please kindly note all other requests to this e-mail will not receive a response.

For general press enquiries, call us at +45 3643 4000

Contact Media Relations

Thomas Mikkel Mortensen

media relations lead

About Lundbeck

H. Lundbeck A/S (HLUNa / HLUNb, HLUNA DC / HLUNB DC) is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.  


Too many people worldwide live with brain diseases – complex conditions often invisible to others that nonetheless take a tremendous toll on individuals, families and societies. We are committed to fighting stigma and discrimination against people living with brain diseases and advocating for broader social acceptance of people with brain health conditions. Every day, we strive for improved treatment and a better life for people living with brain disease.   


We have approximately 5,500 employees in more than 50 countries, and our products are available in more than 100 countries. Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 19.9 billion in 2023.


For additional information, we encourage you to visit our corporate website and connect with us via LinkedIn.  

Media Library

Pictures of our Executive Management, videos, and other assets for download and distribution.

Communication policy

We engage in an open, constructive and continuous dialogue with our stakeholders based on equality and mutual respect.


70 years

In the forefront of neuroscience research


Countries of operation around the world


Employees worldwide

19.9b DKK

Of revenue generated in 2023